Fingolimod hydrochloride
SUPELCO/Y0002055 - European Pharmacopoeia (EP) Reference Standard
Synonym: FTY720; 2-
CAS Number: 162359-56-0
Empirical Formula (Hill Notation): C19H33NO2 · HCl
Molecular Weight: 343.93
Linear Formula: C19H33NO2 · HCl
Product Type: Chemical
| agency | EP |
| application(s) | pharmaceutical |
| biological source | synthetic |
| form | powder |
| format | neat |
| grade | pharmaceutical primary standard |
| InChI | 1S/C19H33NO2.ClH/c1-2-3-4 |
| InChI key | SWZTYAVBMYWFGS-UHFFFAOYSA |
| manufacturer/tradename | EDQM |
| packaging | pkg of 110 mg |
| shipped in | ambient |
| solubility | water: 100-1000 g/L |
| storage condition | protect from light |
| storage temp. | 2-8°C |
| Application: | Fingolimod Hydrochloride EP reference standard may be used as a pharmaceutical primary standard to quantify the analyte in gel, capsule and other pharmaceutical formulations, active pharmaceutical ingredient (API) and pharmaceutical dosage forms by liquid chromatography (LC) based techniques. |
| Biochem/physiol Actions: | FTY720 is an immunomodulating drug and sphingosine 1-phosphate (S1P) receptor modulator. Phosphorylation of FTY270 by sphingosine kinase causes S1P1R internalization, which sequesters lymphocytes in lymph nodes, preventing them from taking part in an autoimmune response. Clinically, it has been approved for the treatment of multiple sclerosis (MS). It has also been shown to block and reverse paclitaxel-induced chemotherapy induced peripheral neuropathy (CIPN) through S1PR inhibition as well as inhibit the activity of histone deacetylases in the hippocampus of mouse brains, thereby modulating memory. |
| General description: | Fingolimod Hydrochloride (fingolimod HCl), an S1P-receptor modulator, belongs to the class of synthetic glucocorticoid steroid drugs. This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets, have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia   . |
| General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia . |
| Other Notes: | Sales restrictions may apply. |
| Packaging: | Unit quantity: 110 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue . |
| Symbol |  GHS08 |
| Signal word | Warning |
| Hazard statements | H373 |
| Precautionary statements | P260 - P314 - P501 |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | 2-8°C |
| UNSPSC | 41116107 |